SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-290084
Filing Date
2019-11-12
Accepted
2019-11-12 16:58:56
Documents
3
Period of Report
2019-11-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d828492d8k.htm 8-K 20735
2 EX-3.1 d828492dex31.htm EX-3.1 28442
3 EX-3.2 d828492dex32.htm EX-3.2 184242
  Complete submission text file 0001193125-19-290084.txt   234583
Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 191210533
SIC: 2834 Pharmaceutical Preparations